Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703611 | SCV000519075 | benign | not provided | 2021-06-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000466777 | SCV000556466 | benign | Tuberous sclerosis 2 | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000466777 | SCV002039326 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002460072 | SCV002618046 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV000466777 | SCV004016173 | likely benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing |